SEARCH

SEARCH BY CITATION

References

  • Baptiste, K., Moll, H.D. and Robertson, J.L. (1996) Three cases of tumors associated with the equine guttural pouch. Can. Vet. J. 37, 499-501.
  • Bowers, J.R., Huntington, P.J. and Slocombe, R.F. (1994) Efficacy of cimetidine for therapy of skin tumours of horses- 10 cases. Aust. Equine Vet. 12, 30-32.
  • Caston, S.S. and Fales-Williams, A. (2010) Primary malignant melanoma in the oesophagus of a foal. Equine Vet. Educ. 22, 387-390.
  • Covington, A.L., Magdesian, K.G., Madigan, J.E., Maleski, K., Gray, L.C., Smith, P.A. and Wisner, E.R. (2004) Recurrent esophageal obstruction and dysphagia due to a brainstem melanoma in a horse. J. Vet. Intern. Med. 18, 245-247.
  • Cox, J.H., DeBowes, R.M. and Leipold, H.W. (1989) Congenital malignant melanoma in two foals. J. Am. Vet. Med. Ass. 194, 945-947.
  • Dick, W. (1832) Letter: Melanosis in men and horses. Lancet 1, 192; as cited by Levene, A. (1971) Equine melanotic disease. Tumori57, 133-168.
  • Ebbs, S.R., Roberts, J.V. and Baum, M. (1987) Alternative mechanism of action of antiestrogens in breast cancer. Lancet 2, 621.
  • Eisenthal, A., Monselise, J., Zinger, R. and Adler, A. (1986) The effect of cimetidine on PBL from healthy donors and melanoma patients: Augmentation of T cell responses to TCGF* mitogens and alloantigens and of TCGF production. Cancer Immunol. Immunother. 21, 141-147.
  • Finocchiaro, L.M.E., Riveros, M.D. and Glikin, G.C. (2009) Cytokine-enhanced vaccine and suicide gene therapy as adjuvant treatments of metastatic melanoma in a horse. Vet. Rec. 164, 278-279.
  • Fleury, C., Berard, F., Balme, B. and Thomas, L. (2000) The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): Clinical-pathological characterization. Pigment Cell Res. 13, 39-46.
  • Goetz, T.E., Ogilvie, G.K., Keegan, K.G. and Johnson, P.J. (1990) Cimetidine for treatment of melanoma in three horses. J. Am. Vet. Med. Ass. 196, 449-452.
  • Hamilton, D.P. and Byerly, C.S. (1974) Congenital malignant melanoma in a foal. J. Am. Vet. Med. Ass. 164, 1040-1041.
  • Heinzerling, L.M., Feige, K., Rieder, S., Akens, M.K., Dummer, R., Stranzinger, G. and Moelling, K. (2001) Tumor regression induced by intratumoral injection of DNA coding for human interleukin 12 into melanoma metastases in gray horses. J. Mol. Med. 78, 692-702.
  • Hewes, C.A. and Sullins, K.E. (2006) Use of cis-platinum containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000-2004). J. Am. Vet. Med. Ass. 229, 1617-1622.
  • Jaeger, A. (1909) Die melanosarkomatose der Schimmelpferde [Melanosarcomatosis of grey horses]. Virchows Arch. Pathol. Anat. Physiol. 198, 1-61.
  • Jeglum, K.A. (1997) Melanomas. In: Current Therapy in Equine Medicine, 4th edn., Ed: N. Robinson, W.B. Saunders, Philadelphia. pp 399-400.
  • Kirker-Head, C.A., Loeffler, D. and Held, J.P. (1985) Pelvic limb lameness due to malignant melanoma in a horse. J. Am. Vet. Med. Ass. 186, 1215-1217.
  • Laus, F., Cerquetella, M., Paggi, E., Ippedico, G., Argentieri, M., Castellano, G., Spaterna, A. and Tesei, B. (2010) Evaluation of cimetidine as a therapy for dermal melanomatosis in grey horse. Israel J. Vet. Med. 65, 48-52.
  • Law, J. (1916) Diseases of the skin. In: Special Report on Diseases of the Horse, Eds: L. Pearson, Ch.B. Michener, J. Law, W.H. Harbaugh, M.R. Trumbower, A. Liautard, A.A. Holcombe, R.S. Huidekoper, J. Mohler, A. Eichhorn, M.C. Hall and J.W. Adams, Government Printing Office, Washington, DC. pp 458-483.
  • Leblanc, P., Cadeac, C. and Carougeau, C. (1902) Pathologie Chirurgicale Generale, Balliere, Paris. pp 353-354.
  • Levene, A. (1979) Disseminated dermal melanocytosis terminating in melanoma. Br. J. Dermatol. 101, 197-205.
  • Levene, A. (1980) On the history and comparative pathology of the Blue Naevus. Ann. R. Coll. Surg. Engl. 62, 327-334.
  • MacGillivray, K., Sweeney, R. and Del Piero, F. (2002) Metastatic melanoma in horses. J. Vet. Intern. Med. 16, 452-456.
  • Mäenpää, J., Dooley, T., Wurz, G., VandeBerg, J., Robinson, E., Emshoff, V., Sipila, P., Wiebe, V., Day, C. and DeGregorio, M. (1993) Topical toremifene: A new approach for cutaneous melanoma? Cancer Chemother. Pharmacol. 32, 392-395.
  • McFadyean, J. (1933) Equine melanomatosis. J. Comp. Pathol. Ther. 46, 186-204.
  • Müller, J., Feige, K., Wunderlin, P., Hödl, A., Meli, M.L., Seltenhammer, M., Grest, P., Nicolson, L., Schelling, C. and Heinzerling, L.M. (2011) Double-blind placebo-controlled study with interleukin-18 and interleukin-12-encoding plasmid DNA shows antitumor effect in metastatic melanoma in gray horses. J. Immunother. 34, 58-64.
  • Murray, M.J., Cavey, D.M., Feldman, B.F., Trostle, S.S. and White, N.A. (1997) Signs of sympathetic denervation associated with thoracic melanoma in a horse. J. Vet. Intern. Med. 11, 199-203.
  • Patterson-Kane, J.C., Sanchez, L.C., Uhl, E.W. and Edens, L.M. (2001) Disseminated metastatic intramedullary melanoma in an aged grey horse. J. Comp. Pathol. 125, 204-207.
  • Pielberg, G., Golovko, A., Sundstrom, E., Curik, I., Lennartsson, J., Seltenhammer, M.H., Druml, T., Binns, M., Fitzsimmons, C., Lindgren, G., Sandberg, K., Baumung, R., Vetterlein, M., Stromberg, S., Grabherr, M., Wade, C., Lindblad-Toh, K., Ponten, F., Heldin, C., Solkner, J. and Andersson, L. (2008) A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat. Genet. 40, 1004-1009.
  • Pulley, L.T. and Stannard, A.A. (1990) Tumors of the skin and soft tissues. In: Tumors in Domestic Animals, 3rd edn., Ed: J.E. Moulton, University of California Press, Berkley. pp 75-82.
  • Robertson, J. (1996) Melanoma. In: Equine Pathology, Eds: J. Rooney and J. Robertson, Iowa State University Press, Ames. pp 304-305.
  • Rodriguez, F., Forga, J., Herraez, P., Andrade, M. and Fernandez, M. (1998) Metastatic melanoma causing spinal cord compression in a horse. Vet. Rec. 142, 248-249.
  • Rodriguez, M., Garcia-Barona, J., Pera, L., Castano, M. and Rodriguez, A. (1997) A grey horse melanotic condition: a pigmentary disorder. J. Equine Vet. Sci. 17, 677-681.
  • Rowe, E. and Sullins, K. (2004) Excision for treatment of dermal melanomatosis in horses: 11 cases (1994-2000). J. Am. Vet. Med. Ass. 225, 94-96.
  • Runnells, R.A. and Benbrook, E.A. (1941) Malignant melanoma of horses and mules. Am. J. Vet. Res. 2, 340-344.
  • Rywlin, A.M. (1989) Malignant melanoma in light of the multistep theory of neoplasia. Am. J. Dermatopathol. 11, 387-389.
  • Sahasrabudhe, D.M., McCune, C.S., O'Donnell, R.W. and Henshaw, E.C. (1987) Inhibition of suppressor T-Lymphocytes (Ts) by cimetidine. J. Immunol. 138, 2760-2763.
  • Schott, H.C., Major, M.D., Grant, B.D. and Bayly, W.M. (1990) Melanoma as a cause of spinal cord compression in two horses. J. Am. Vet. Med. Ass. 196, 1820-1822.
  • Scott, D.W. (1988) Neoplastic diseases. In: Large Animal Dermatology, W.B. Saunders, Philadelphia. pp 448-452.
  • Seltenhammer, M.H., Heere-Ress, E., Brandt, S., Druml, T., Jansen, B., Pehamberger, H. and Niebauer, G.W. (2004) Comparative histopathology of grey-horse-melanoma and human malignant melanoma. Pigment Cell Res. 17, 674-681.
  • Seltenhammer, M.H., Simhofer, H., Scherzer, S., Zechner, P., Curik, I., Sölkner, J, Brandt, S.M., Jansen, B., Pehamberger, H. and Eisenmenger, E. (2003) Equine melanoma in a population of 296 grey Lipizzaner horses. Equine Vet. J. 35, 153-157.
  • Soe, L., Wurz, G.T., Maenpaa, J.U., Hubbard, G.B., Cadman, T.B., Wiebe, V.J., Theon, A.P. and Degregorio, M.W. (1997) Tissue distribution of transdermal toremifene. Cancer Chemother. Pharmacol. 39, 513-520.
  • Tarrant, J., Stokol, T., Bartol, J., Wakshlag, J. and Blue, J. (2001) Diagnosis of malignant melanoma in a horse from cytology of body cavity fluid and blood. Equine Vet. J. 33, 531-535.
  • Theon, A.P., Magdesian, K.G. and Snyder, J.R. (2007) Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995-2004). J. Am. Vet. Med. Ass. 230, 1506-1513.
  • Traver, D.S., Moore, J.N., Thornburg, L.P., Johnson, J.H. and Coffman, J.R. (1977) Epidural melanoma causing posterior paresis in a horse. J. Am. Vet. Med. Ass. 179, 1400-1140.
  • Valavaara, R., Pyrhonen, S., Heikkinen, M., Rissanen, P., Blanco, G., Tholix, E., Nordman, E., Taskinen, P., Holsti, L. and Hajba, A. (1988) Toremifene, a new antiestrogenic compound for treatment of advanced breast cancer. Phase II study. Eur. J. Cancer 24, 785-790.
  • Valentine, B. (1995) Equine melanocytic tumors: A retrospective study of 53 horses. J. Vet. Intern. Med. 9, 291-297.
  • Warnick, L.D., Graham, M.E. and Valentine, B.A. (1995) Evaluation of cimetidine treatment for melanomas in seven horses. Equine Pract. 17, 16-22.
  • Whitehead, R.J., Taylor, D.J., Evanson, J.M., Hart, I.R. and Woolley, D.E. (1988) Demonstration of histamine H2 receptors on human melanoma cells. Biochem. Biophys. Res. Commun. 29, 518-523.